Independent minds. Global perspective. A publication for the builders
Biotechnology / Lund, Sweden

Mattias Akke.

Co-founder
Halmos Labs

Mattias Akke is a founder of Halmos Labs, which develops computational tools for biotechnology research and experiment design. His background includes research at MIT, AstraZeneca and Cambridge, covering optimisation, drug discovery models and protein related questions. He also chaired Kodsport Sverige, an organisation supporting competitive programming in Sweden.

Public-source researchLast checked 1 source ↘
THE STORY, IN CONTEXT

Mattias Akke and the story of Halmos Labs.

Halmos' launch focuses on deciding which experiments to run and how much information a team can obtain from them. It describes coordinating literature research, simulations and model selection, with checks on the reasoning before presenting conclusions. The initial scope is experiment design, while broader research programmes are an ambition. Akke's research experience explains the selected domain without establishing that the system has completed the full drug development or manufacturing tasks mentioned as possibilities.

FROM THE PUBLIC RECORD

Public advice & further reading.

No personal advice is attributed in this profile: a verifiable public advice source has not yet been established. The company and activity facts above remain separately sourced.

Suggest a first-person interview or essay ↗
EVIDENCE IN PLAIN SIGHT

Sources & attribution.

  1. 01
    Halmos Labs — Y Combinator company and active founder profile

    Public active-founder biography, current company status and description, and founding-team launch accounts. Company or team statements are attributed accounts, not independently audited performance results.

    www.ycombinator.com
About this profile

Independently researched from the public sources above. Featured people and companies are not affiliated with BusinessBlogz. Source dates and attribution provide context for the information shown; business claims remain attributed to their original source. Role and company details can change after review. The initials graphic is editorial artwork, not a photograph.

Request a correction or update ↗
KEEP EXPLORING

More builders in Biotechnology.

Explore the sector ↗